-
1
-
-
42049092525
-
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1, 007 isolates of zygomycete, candida, aspergillus, fusarium, and scedosporium species
-
Guinea J, Pelaez T, Recio S, Torres-Narbona M, Bouza E. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1, 007 isolates of zygomycete, candida, aspergillus, fusarium, and scedosporium species. Antimicrob Agents Chemother. 2008; 52: 1396-400.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1396-1400
-
-
Guinea, J.1
Pelaez, T.2
Recio, S.3
Torres-Narbona, M.4
Bouza, E.5
-
2
-
-
42049109270
-
In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba
-
Illnait-Zaragozi MT, Martinez GF, Curfs-Breuker I, Fernandez CM, Boekhout T, Meis JF. In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother. 2008; 52: 1580-2.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1580-1582
-
-
Illnait-Zaragozi, M.T.1
Martinez, G.F.2
Curfs-Breuker, I.3
Fernandez, C.M.4
Boekhout, T.5
Meis, J.F.6
-
3
-
-
30344449770
-
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp
-
Warn PA, Sharp A, Denning DW. In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp. J Antimicrob Chemother. 2006; 57: 135-8.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 135-138
-
-
Warn, P.A.1
Sharp, A.2
Denning, D.W.3
-
4
-
-
34248379039
-
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates
-
Seifert H, Aurbach U, Stefanik D, Cornely O. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother. 2007; 51: 1818-21.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 1818-1821
-
-
Seifert, H.1
Aurbach, U.2
Stefanik, D.3
Cornely, O.4
-
5
-
-
33646538016
-
Dose response curves and dose fractionation studies with BAL8557 in a Murine Model of Disseminated Candidiasis
-
Washington, DC 2005. Poster B-47
-
Warn PA, Hope W, Sharp A, Drusano G, Walsh T, Denning DW. Dose response curves and dose fractionation studies with BAL8557 in a Murine Model of Disseminated Candidiasis. In: Programs and abstracts of the 45th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC). Washington, DC 2005. Poster B-47.
-
Programs and abstracts of the 45th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC)
-
-
Warn, P.A.1
Hope, W.2
Sharp, A.3
Drusano, G.4
Walsh, T.5
Denning, D.W.6
-
6
-
-
17644440661
-
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole
-
Ohwada J, Tsukazaki M, Hayase T, et al. Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorg Med Chem Lett. 2003; 13: 191-6.
-
(2003)
Bioorg Med Chem Lett.
, vol.13
, pp. 191-196
-
-
Ohwada, J.1
Tsukazaki, M.2
Hayase, T.3
-
7
-
-
41949128129
-
New and emerging treatments for fungal infections
-
Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother. 2008; 61(Suppl 1): i19-30.
-
(2008)
J Antimicrob Chemother
, vol.61
, Issue.SUPPL. 1
-
-
Pasqualotto, A.C.1
Denning, D.W.2
-
8
-
-
33845356887
-
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus
-
Warn PA, Sharp A, Mosquera J, et al. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006; 58: 1198-207.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. 1198-1207
-
-
Warn, P.A.1
Sharp, A.2
Mosquera, J.3
-
10
-
-
78049340436
-
In vitro activity of isavuconazole (BAL4815) compared with seven other antifungal agents against 309 prospectively collected clinical candida isolates from The Netherlands
-
Munich Poster P1978
-
Curfs-Breuker IM, Mouton J, Debets-Ossenkopp YJ, Endtz HP, Verweij PE, Meis JF. In vitro activity of isavuconazole (BAL4815) compared with seven other antifungal agents against 309 prospectively collected clinical candida isolates from The Netherlands. In: Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID). Munich 2007. Poster P1978.
-
(2007)
Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID)
-
-
Curfs-Breuker, I.M.1
Mouton, J.2
Debets-Ossenkopp, Y.J.3
Endtz, H.P.4
Verweij, P.E.5
Meis, J.F.6
-
12
-
-
84926308054
-
Evaluation of isavuconazole e-test compared to broth microdilution antifungal susceptibility testing against quality control strains and clinical candida isolates
-
Munich Poster P-1676
-
Heep M, Grover P, Brown NP, Pillar CM, Jones ME, Sahm DF. Evaluation of isavuconazole e-test compared to broth microdilution antifungal susceptibility testing against quality control strains and clinical candida isolates. In: Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID). Munich 2007. Poster P-1676.
-
(2007)
Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID)
-
-
Heep, M.1
Grover, P.2
Brown, N.P.3
Pillar, C.M.4
Jones, M.E.5
Sahm, D.F.6
-
14
-
-
59749083143
-
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans
-
Thompson GR III, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother. 2009; 53: 309-11.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 309-311
-
-
Thompson III, G.R.1
Wiederhold, N.P.2
Fothergill, A.W.3
Vallor, A.C.4
Wickes, B.L.5
Patterson, T.F.6
-
15
-
-
48749109549
-
Evaluation of E-test method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans
-
Thompson GR III, Fothergill AW, Wiederhold NP, Vallor AC, Wickes BL, Patterson TF. Evaluation of E-test method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother. 2008; 52: 2959-61.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 2959-2961
-
-
Thompson III, G.R.1
Fothergill, A.W.2
Wiederhold, N.P.3
Vallor, A.C.4
Wickes, B.L.5
Patterson, T.F.6
-
16
-
-
78049339095
-
Antifungal activity of old and new antifungal agents against 94 clinical isolates of Cryptococcus neoformans var. grubii and var. neoformans: Are there differences between the varieties?
-
Washington
-
Guinea J, Pelaez T, Tahoune H, Recio S, Torres-Narbona M, Hagen F, Boikhout T, Bouza E. Antifungal activity of old and new antifungal agents against 94 clinical isolates of Cryptococcus neoformans var. grubii and var. neoformans: are there differences between the varieties? In: Programs and Abstracts of the 48th Annual ICAAC Annual Meeting. Washington 2008.
-
(2008)
Programs and Abstracts of the 48th Annual ICAAC Annual Meeting
-
-
Guinea, J.1
Pelaez, T.2
Tahoune, H.3
Recio, S.4
Torres-Narbona, M.5
Hagen, F.6
Boikhout, T.7
Bouza, E.8
-
17
-
-
84926329684
-
In vitro activity of isavuconazole (BAL4815) Compared with six other antifungal agents against 180 cryptococcus neoformans meningitis isolates from The Netherlands
-
Poster P-1977
-
Curfs-Breuker IM, Mouton J, Janssen BGJ, Illnait-Zaragozi, Hagen F. Spanjaard L, Boekhout T, Meis JF. In vitro activity of isavuconazole (BAL4815) Compared with six other antifungal agents against 180 cryptococcus neoformans meningitis isolates from The Netherlands. In: Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID). Munich 2007. Poster P-1977.
-
(2007)
Programs and abstracts of the 17th European congress of clinical microbiology and infectious diseases (ECCMID). Munich
-
-
Curfs-Breuker, I.M.1
Mouton, J.2
Janssen, B.G.J.3
Illnait-Zaragozi, H.F.4
Spanjaard, L.5
Boekhout, T.6
Meis, J.F.7
-
18
-
-
67249103186
-
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
-
Thompson GR III, Wiederhold NP, Sutton DA, Fothergill A, Patterson TF. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. J Antimicrob Chemother. 2009; 64: 79-83.
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 79-83
-
-
Thompson III, G.R.1
Wiederhold, N.P.2
Sutton, D.A.3
Fothergill, A.4
Patterson, T.F.5
-
19
-
-
65649120454
-
In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing
-
Perkhofer S, Lechner V, Lass-Florl C. In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother. 2009; 53: 1645-7.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1645-1647
-
-
Perkhofer, S.1
Lechner, V.2
Lass-Florl, C.3
-
20
-
-
34250341823
-
A higher-level phylogenetic classification of the Fungi
-
Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007; 111: 509-47.
-
(2007)
Mycol Res
, vol.111
, pp. 509-547
-
-
Hibbett, D.S.1
Binder, M.2
Bischoff, J.F.3
-
21
-
-
33744463904
-
Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases
-
van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006; 42: e61-5.
-
(2006)
Clin Infect Dis
, vol.42
-
-
van Burik, J.A.1
Hare, R.S.2
Solomon, H.F.3
Corrado, M.L.4
Kontoyiannis, D.P.5
-
22
-
-
33644661057
-
Head-to-head comparison of the activities of currently available antifungal agents against 3, 378 Spanish clinical isolates of yeasts and filamentous fungi
-
Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3, 378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006; 50: 917-21.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 917-921
-
-
Cuenca-Estrella, M.1
Gomez-Lopez, A.2
Mellado, E.3
Buitrago, M.J.4
Monzon, A.5
Rodriguez-Tudela, J.L.6
-
23
-
-
67449108546
-
Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi
-
Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol. 2009; 47: 422-32.
-
(2009)
Med Mycol.
, vol.47
, pp. 422-432
-
-
Wiederhold, N.P.1
Lewis, R.E.2
-
25
-
-
33747622240
-
Antifungal activity of BAL4815, a novel azole against dermatophytes and emerging non-dermatophyte fungi including zygomycetes
-
New Orleans Poster M-1623
-
Ghannoum M, Isham N. Antifungal activity of BAL4815, a novel azole against dermatophytes and emerging non-dermatophyte fungi including zygomycetes. In: Programs and abstracts of the 45th annual ICAAC annual meeting. New Orleans 2005. Poster M-1623.
-
(2005)
Programs and abstracts of the 45th annual ICAAC annual meeting
-
-
Ghannoum, M.1
Isham, N.2
-
26
-
-
58149197661
-
In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi
-
Gonzalez GM. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi. Med Mycol. 2009; 47: 71-6.
-
(2009)
Med Mycol.
, vol.47
, pp. 71-76
-
-
Gonzalez, G.M.1
-
28
-
-
0034944963
-
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature
-
Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia. 2001; 150: 101-15.
-
(2001)
Mycopathologia
, vol.150
, pp. 101-115
-
-
Espinel-Ingroff, A.1
Boyle, K.2
Sheehan, D.J.3
-
29
-
-
67749102126
-
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect
-
Warn PA, Sharp A, Parmar A, Majithiya J, Denning DW, Hope WW. Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect. Antimicrob Agents Chemother. 2009; 53: 3453-61.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3453-3461
-
-
Warn, P.A.1
Sharp, A.2
Parmar, A.3
Majithiya, J.4
Denning, D.W.5
Hope, W.W.6
-
30
-
-
78049326478
-
In vitro post antibiotic effect of isavuconazole, voriconazole, and amphotericin B against a strain of C. albicans with concentration dependent pharmacokinetics in a murine model and susceptibility of strains from mouse kidneys post infection
-
Barcelona: Poster P-2177
-
Warn PA, Sharp A, Majithiya JB, Parmar A, Denning DW. In vitro post antibiotic effect of isavuconazole, voriconazole, and amphotericin B against a strain of C. albicans with concentration dependent pharmacokinetics in a murine model and susceptibility of strains from mouse kidneys post infection. In: Programs and abstracts of the 18th European congress of clinical microbiology and infectious diseases (ECCMID). Barcelona: 2008. Poster P-2177.
-
(2008)
Programs and abstracts of the 18th European congress of clinical microbiology and infectious diseases (ECCMID)
-
-
Warn, P.A.1
Sharp, A.2
Majithiya, J.B.3
Parmar, A.4
Denning, D.W.5
-
31
-
-
29944441643
-
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers
-
Schmitt-Hoffmann A, Roos B, Heep M, et al. Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers. Antimicrob Agents Chemother. 2006; 50: 279-85.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 279-285
-
-
Schmitt-Hoffmann, A.1
Roos, B.2
Heep, M.3
-
32
-
-
57649180452
-
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei
-
Majithiya J, Sharp A, Parmar A, Denning DW, Warn PA. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. J Antimicrob Chemother. 2009; 63: 161-6.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 161-166
-
-
Majithiya, J.1
Sharp, A.2
Parmar, A.3
Denning, D.W.4
Warn, P.A.5
-
33
-
-
78049342495
-
Dose response curves and dose fractionation studies with BAL8557 in a murine model of disseminated aspergillosis
-
San Francisco A-1120
-
Warn PA, Sharp A, Denning D. Dose response curves and dose fractionation studies with BAL8557 in a murine model of disseminated aspergillosis. In: Programs and abstracts of the 46th ICAAC meeting. San Francisco 2006. A-1120.
-
(2006)
Programs and abstracts of the 46th ICAAC meeting
-
-
Warn, P.A.1
Sharp, A.2
Denning, D.3
-
34
-
-
78049333446
-
Dose response in neutropenic mice with disseminated infection of multiple strains of Aspergillus fumigatus with widely varying MIC and MFC values treated with isavuconazole
-
Munich P-1951
-
Warn PA, Sharp A, Denning DW. Dose response in neutropenic mice with disseminated infection of multiple strains of Aspergillus fumigatus with widely varying MIC and MFC values treated with isavuconazole. In: Programs and abstracts of the 17th ECCMID meeting. Munich 2008. P-1951.
-
(2008)
Programs and abstracts of the 17th ECCMID meeting
-
-
Warn, P.A.1
Sharp, A.2
Denning, D.W.3
-
35
-
-
85046687649
-
Correlation of in vitro MIC and MFC against isavuconazole, voriconazole, and amphotericin B of Aspergillus with in vivo outcome in mice with disseminated Aspergillosis
-
Barcelona P1915
-
Majithiya JB, Sharp A, Parmar A, Denning DW, Warn PA. Correlation of in vitro MIC and MFC against isavuconazole, voriconazole, and amphotericin B of Aspergillus with in vivo outcome in mice with disseminated Aspergillosis. In: Programs and abstracts of the 18th ECCMID meeting. Barcelona 2008. P1915.
-
(2008)
Programs and abstracts of the 18th ECCMID meeting
-
-
Majithiya, J.B.1
Sharp, A.2
Parmar, A.3
Denning, D.W.4
Warn, P.A.5
-
36
-
-
78049344717
-
No relevant food effect in man on isavuconazole oral pharmacokinetics preliminary data
-
Washington: Poster A-008
-
Schmitt-Hoffman A, Roos B, Roehrle M, Spickermann J, Schoetzau A, Simmen U, Heep M. No relevant food effect in man on isavuconazole oral pharmacokinetics preliminary data. In: Programs and abstracts of the 48th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC). Washington: Poster A-008.
-
Programs and abstracts of the 48th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC)
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Roehrle, M.3
Spickermann, J.4
Schoetzau, A.5
Simmen, U.6
Heep, M.7
-
37
-
-
78049345691
-
Pharmacokinetics, safety and tolerability results from a dose escalation study of isavuconazole in neutropenic patients
-
Washington: Poster M-2137
-
Cornely OA, Böhme A, Reichert D, Heep M, Roos B, Schmitt-Hoffman A, Ullman AJ. Pharmacokinetics, safety and tolerability results from a dose escalation study of isavuconazole in neutropenic patients. In: Programs and abstracts of the 48th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC). Washington: Poster M-2137.
-
Programs and abstracts of the 48th annual international interscience conference on antimicrobial agents and chemotherapy (ICAAC)
-
-
Cornely, O.A.1
Böhme, A.2
Reichert, D.3
Heep, M.4
Roos, B.5
Schmitt-Hoffman, A.6
Ullman, A.J.7
-
38
-
-
78049322443
-
Oral pharmacokinetics of isavuconazole in liver impairment due to cirrhosis
-
Helskinki Poster P-1665
-
Schmitt-Hoffman A, Roos B, Peterfai E, Edwards D, Spickermann J, Heep M. Oral pharmacokinetics of isavuconazole in liver impairment due to cirrhosis. In: Programs and abstracts of the 19th European congress of clinical microbiology and infectious diseases (ECCMID). Helskinki 2009. Poster P-1665.
-
(2009)
Programs and abstracts of the 19th European congress of clinical microbiology and infectious diseases (ECCMID)
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Peterfai, E.3
Edwards, D.4
Spickermann, J.5
Heep, M.6
-
39
-
-
78049320929
-
Pharmacokinetics of isavuconazole in liver impairment-preliminary data
-
San Francisco
-
Schmitt-Hoffman A, Roos B, Peterfai E, Edwards D, Spickermann J, Heep M. Pharmacokinetics of isavuconazole in liver impairment-preliminary data. In: Programs and abstracts of the 49th annual ICAAC annual meeting. San Francisco 2009.
-
(2009)
Programs and abstracts of the 49th annual ICAAC annual meeting
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Peterfai, E.3
Edwards, D.4
Spickermann, J.5
Heep, M.6
-
42
-
-
78049344876
-
QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimen of isavuconazole
-
Munich Poster P-1675
-
Heep M, Roos B, Sochor M, Schmitt-Hoffmann A, van Marle S, Kappe D, Voiriot P. QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimen of isavuconazole. In: Abstracts and proceedings of the 17th annual European congress of clinical microbiology and infectious diseases (ECCMID). Munich 2007. Poster P-1675.
-
(2007)
Abstracts and proceedings of the 17th annual European congress of clinical microbiology and infectious diseases (ECCMID)
-
-
Heep, M.1
Roos, B.2
Sochor, M.3
Schmitt-Hoffmann, A.4
van Marle, S.5
Kappe, D.6
Voiriot, P.7
-
43
-
-
84874937332
-
Efficacy, safety, and tolerability of three different dosing regimens of BAL8557 vs fluconazole in a double-blind randomized, multicenter trial for ther treatment of esophageal candidiasis in immunocompromised adults
-
Washington., Abstracct LB2-32. American Society for Microbiology, Washington
-
Viljoen JJ, Mitha I, Heep M, et al. Efficacy, safety, and tolerability of three different dosing regimens of BAL8557 vs fluconazole in a double-blind randomized, multicenter trial for ther treatment of esophageal candidiasis in immunocompromised adults. In: Abstracts of the forty-fifth interscience conference on antimicrobial agents and chemotherapy. Washington 2005. Abstracct LB2-32. American Society for Microbiology, Washington.
-
(2005)
Abstracts of the forty-fifth interscience conference on antimicrobial agents and chemotherapy
-
-
Viljoen, J.J.1
Mitha, I.2
Heep, M.3
-
45
-
-
77649136588
-
Effect of BAL8557, a water-soluble azole pro-drug (WSA), on the pharmacokinetics of S- and R-warfarin
-
Paris P-0321
-
Schmitt-Hoffman A, Roos B, Sauer J, et al. Effect of BAL8557, a water-soluble azole pro-drug (WSA), on the pharmacokinetics of S- and R-warfarin. In: Abstracts of the sixteenth congress of the international society for human and animal mycology (ISHAM), Paris 2006, P-0321.
-
(2006)
Abstracts of the sixteenth congress of the international society for human and animal mycology (ISHAM)
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Sauer, J.3
-
46
-
-
77649136588
-
Effect of BAL8557, a water-soluble azole pro-drug (WSA), on the pharmacokinetics of ciclosporin
-
Paris, P-0136
-
Schmitt-Hoffman A, Roos B, Sauer J, et al. Effect of BAL8557, a water-soluble azole pro-drug (WSA), on the pharmacokinetics of ciclosporin. In: Abstracts of the sixteenth congress of the international society for human and animal mycology (ISHAM), Paris 2006, P-0136.
-
(2006)
Abstracts of the sixteenth congress of the international society for human and animal mycology (ISHAM)
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Sauer, J.3
-
47
-
-
77649136588
-
Effect of BAL8557, a Water-soluble Azole Pro-Drug (WSA) on the pharmacokinetics of Tacrolimus
-
Paris Poster P-0320
-
Schmitt-Hoffman A, Roos B, Sauer J, Maares J, Brown T, Spickermann J, Roehrle M, Thomann P, Heep M. Effect of BAL8557, a Water-soluble Azole Pro-Drug (WSA) on the pharmacokinetics of Tacrolimus. In: Programs and abstracts of the international society of human and animal mycoses (ISHAM). Paris 2006. Poster P-0320.
-
(2006)
Programs and abstracts of the international society of human and animal mycoses (ISHAM)
-
-
Schmitt-Hoffman, A.1
Roos, B.2
Sauer, J.3
Maares, J.4
Brown, T.5
Spickermann, J.6
Roehrle, M.7
Thomann, P.8
Heep, M.9
-
48
-
-
38149113811
-
Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis
-
Wahyuningsih R, SahBandar IN, Theelen B, et al. Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis. J Clin Microbiol. 2008; 46: 388-91.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 388-391
-
-
Wahyuningsih, R.1
Sahbandar, I.N.2
Theelen, B.3
-
49
-
-
66749159129
-
Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov
-
Taj-Aldeen SJ, Al-Ansari N, El Shafei S, et al. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol. 2009; 47: 1791-9.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 1791-1799
-
-
Taj-Aldeen, S.J.1
Al-Ansari, N.2
El Shafei, S.3
-
51
-
-
78049327388
-
Is Aspergillus nidulans susceptible to all antifungal agents? in vitro activity of and updated panel of antifungal agents against 63 clinical isolates
-
Oral Presentation
-
Pelaez T, Guinea J, Gama B, Flores R, Recio S, Torres-Narbona M, Munoz P, Bouza E. Is Aspergillus nidulans susceptible to all antifungal agents? in vitro activity of and updated panel of antifungal agents against 63 clinical isolates. In: Programs and abstracts of the 19th european congress of clinical microbiology and infectious diseases (ECCMID). Helskinki 2009. Oral Presentation.
-
(2009)
Programs and abstracts of the 19th european congress of clinical microbiology and infectious diseases (ECCMID). Helskinki
-
-
Pelaez, T.1
Guinea, J.2
Gama, B.3
Flores, R.4
Recio, S.5
Torres-Narbona, M.6
Munoz, P.7
Bouza, E.8
-
52
-
-
84926359578
-
Assessment of the antifungal susceptibility of Aspergillus terreus over an 18-year period in a general hospital
-
Poster M1714
-
Pelaez T, Gama B, Guinea J, Sanchez-Cambronero L, Martin-Rabadan P, Flores R, Alcala L, Munoz P, Bouza E. Assessment of the antifungal susceptibility of Aspergillus terreus over an 18-year period in a general hospital. In: Programs and abstracts of the 49th annual ICAAC annual meeting. San Francisco 2009. Poster M1714.
-
(2009)
Programs and abstracts of the 49th annual ICAAC annual meeting. San Francisco
-
-
Pelaez, T.1
Gama, B.2
Guinea, J.3
Sanchez-Cambronero, L.4
Martin-Rabadan, P.5
Flores, R.6
Alcala, L.7
Munoz, P.8
Bouza, E.9
-
53
-
-
68349106776
-
In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries
-
Verweij PE, Gonzalez GM, Wiedrhold NP, et al. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother. 2009; 21: 272-81.
-
(2009)
J Chemother
, vol.21
, pp. 272-281
-
-
Verweij, P.E.1
Gonzalez, G.M.2
Wiedrhold, N.P.3
-
57
-
-
33746084037
-
Pharmacology of systemic antifungal agents
-
Dodds Ashley ES, Lewis R, Lewis JS, Martin C, Andes D. Pharmacology of systemic antifungal agents. Clin Infect Dis. 2006; 43: S28-39.
-
(2006)
Clin Infect Dis
, vol.43
-
-
Dodds Ashley, E.S.1
Lewis, R.2
Lewis, J.S.3
Martin, C.4
Andes, D.5
-
59
-
-
78049344547
-
-
Diflucan [package insert]. New York NR 2004
-
Diflucan [package insert]. New York NR 2004.
-
-
-
-
60
-
-
78049327552
-
-
Sporanox [package insert]. Titusville NJP 2004
-
Sporanox [package insert]. Titusville NJP 2004.
-
-
-
-
61
-
-
78049353010
-
-
Posaconazole [package insert]. Kenilworth NSC
-
Posaconazole [package insert]. Kenilworth NSC.
-
-
-
-
62
-
-
78049350605
-
-
Vfend package insert; Pfizer Inc. NY
-
Vfend package insert; Pfizer Inc. NY.
-
-
-
|